Pancreatic Cancer and Tumor

When aberrant pancreatic cells proliferate unchecked and develop into a tumour, pancreatic cancer begins. The exocrine and endocrine cell types, both of which are present in the pancreas and perform a variety of tasks, are both present. Exocrine tumours are thought to account for about 94% of pancreatic cancer cases. The exocrine cells that produce pancreatic enzymes, which aid in digesting, are where the tumours first appear. In this category, adenocarcinomas make up the majority of tumours. The percentage of pancreatic neuroendocrine tumours is approximately 6%. Surgery, chemotherapy, radiation therapy, or a combination of these therapies may all be used to treat pancreatic cancer.


    Related Conference of Pancreatic Cancer and Tumor

    April 17-18, 2023

    18th Euro-Global Gastroenterology Conference

    Rome, Italy
    May 22-23, 2023

    14th International Conference on Liver Diseases & Hepatology

    Amsterdam, Netherlands
    July 18-19, 2023

    2nd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    July 26-27, 2023

    11th International Conference on Hepatitis & Liver Diseases

    Singapore City, Singapore
    August 23-24, 2023

    29th World Conference on Gastroenterology & Hepatology

    Toronto, Canada
    August 30-31, 2023

    22nd World Congress on Gastrointestinal Cancer

    Dublin, Ireland
    November 29-30, 2023

    12th World Gastro Summit

    Amsterdam, Netherlands

    Pancreatic Cancer and Tumor Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in